How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future Directions

Pathogens
Flora Teoh, Norman Pavelka

Abstract

Candida albicans is a fungal commensal and a major colonizer of the human skin, as well as of the gastrointestinal and genitourinary tracts. It is also one of the leading causes of opportunistic microbial infections in cancer patients, often presenting in a life-threatening, systemic form. Increased susceptibility to such infections in cancer patients is attributed primarily to chemotherapy-induced depression of innate immune cells and weakened epithelial barriers, which are the body's first-line defenses against fungal infections. Moreover, classical chemotherapeutic agents also have a detrimental effect on components of the adaptive immune system, which further play important roles in the antifungal response. In this review, we discuss the current paradigm regarding the mechanisms behind the increased risk of systemic candidiasis in cancer patients. We also highlight some recent findings, which suggest that chemotherapy may have more extensive effects beyond the human host, in particular towards C. albicans itself and the bacterial microbiota. The extent to which these additional effects contribute towards the development of candidiasis in chemotherapy-treated patients remains to be investigated.

References

Feb 8, 1990·The New England Journal of Medicine·C G MoertelJ H Glick
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J M SechlerJ I Gallin
Jul 30, 1988·Lancet·R MatthewsB Gazzard
Oct 1, 1983·Journal of Clinical Pathology·S MartinJ A Child
Dec 1, 1981·British Journal of Cancer·M GandossiniM C Berenbaum
Dec 1, 1981·The Journal of Dermatologic Surgery and Oncology·P B Lockhart, S T Sonis
Jun 1, 1997·Infection and Immunity·E M PorterT Ganz
Sep 23, 1997·Cell·H J LoG R Fink
Nov 14, 1997·Diagnostic Microbiology and Infectious Disease·J A KarlowskyA M Kabani
Nov 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A M RentzR Bowden
Feb 20, 1999·American Journal of Clinical Oncology·M KondoK Noda
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A S KaoR A Hajjeh
Jul 4, 2001·Trends in Microbiology·R A Calderone, W A Fonzi
Jul 10, 2001·Oral Microbiology and Immunology·E UetaT Osaki
Nov 6, 2001·Journal of the National Cancer Institute. Monographs·S A Khan, J R Wingard
Nov 10, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M Nucci, E Anaissie
Feb 15, 2002·Advances in Dental Research·M Edgerton, S E Koshlukova
May 22, 2002·Nature Immunology·Dipankar GhoshCharles L Bevins
Jul 13, 2002·Cancer·Nadége CarelleDavid Khayat
Oct 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Chung-Yu LanNina Agabian
Jan 8, 2003·The Journal of Experimental Medicine·Kevin J MaloyFiona Powrie
Aug 28, 2003·Experimental Cell Research·Maria T Damiani, Maria I Colombo
Oct 15, 2003·Clinical Microbiology Reviews·Timothy Andrews, Kathleen E Sullivan
Nov 1, 2003·The Lancet Infectious Diseases·Philippe EggimannDidier Pittet
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hilmar WisplinghoffMichael B Edmond
Oct 13, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Klastersky, M Aoun
Oct 27, 2004·Infection and Immunity·Mairi C Noverr, Gary B Huffnagle
Dec 3, 2004·Journal of the American Society of Nephrology : JASN·Benjamin D HumphreysColm C Magee
May 11, 2005·The Journal of Experimental Medicine·Anne M ErcoliniElizabeth M Jaffee
Sep 9, 2005·The Journal of Experimental Medicine·Antonella TorosantucciAntonio Cassone
Mar 22, 2006·Cellular Microbiology·Constantin F UrbanArturo Zychlinsky
Apr 22, 2006·The EMBO Journal·Karla J DanielsDavid R Soll

❮ Previous
Next ❯

Citations

Feb 17, 2017·Frontiers in Microbiology·Shih-Hung HsiehMatthias Brock
Dec 5, 2017·Frontiers in Cellular and Infection Microbiology·Nick CarpinoJames B Konopka
Nov 3, 2017·Journal of Drug Targeting·Chun Y WongCrispin R Dass
Apr 23, 2019·PLoS Pathogens·Martinna BertoliniAnna Dongari-Bagtzoglou
Apr 28, 2019·Molecular Biology and Evolution·Feng YangJudith Berman
Jun 20, 2019·Journal of Biomaterials Science. Polymer Edition·Jéssica Aparecida Ribeiro AmbrosioAndreza Ribeiro Simioni
May 15, 2018·Frontiers in Immunology·Gloria Hoi Wan TsoNorman Pavelka
Nov 12, 2019·EMBO Molecular Medicine·Agata SzadeAlicja Józkowicz
Jul 22, 2020·Critical Reviews in Microbiology·Diletta Francesca SquarzantiBarbara Azzimonti
Aug 4, 2020·Mycoses·Jeffrey D JenksMartin Hoenigl
Sep 25, 2019·Journal of Fungi·Martinna Bertolini, Anna Dongari-Bagtzoglou
Jul 19, 2020·BMC Veterinary Research·Bożena Dworecka-KaszakIwona Dąbrowska
Mar 7, 2020·Indian Journal of Palliative Care·Jagjit Singh DhaliwalMunikumar Ramasamy Venkatasalu
Nov 5, 2019·Bio-protocol·Takanori SobueAnna Dongari-Bagtzoglou
Aug 24, 2021·Antimicrobial Agents and Chemotherapy·Anna DahlmanGanna Petruk
Oct 19, 2017·ACS Infectious Diseases·Jason M BurchCatherine L Grimes
Sep 1, 2021·Periodontology 2000·Cristina Cunha Villar, Anna Dongari-Bagtzoglou
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·S JayashreeDipita Bhakta-Guha
Nov 4, 2019··Martinna BertoliniAnna Dongari-Bagtzoglou

❮ Previous
Next ❯

Methods Mentioned

BETA
chemical treatments

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.